国际参考价格在药品价格监测中的应用研究——以加拿大为例

发布时间：2018-03-18 17:36

本文选题：国际参考价格　切入点：药品价格监测　出处：《中国卫生政策研究》2017年02期 　论文类型：期刊论文

【摘要】：目的:分析总结加拿大基于国际参考价格的药品价格监测模式,以期为完善我国药品价格监测体系提供参考。方法:通过政策分析和文献研究,系统梳理加拿大采用国际参考价格进行药价监测的具体做法。结果:对于引入期的新药,加拿大采用国际中位价格比较测试、最高国际价格比较测试、国内治疗类别比较测试和国际治疗类别比较测试四种方法监测其药品价格;对于已上市的药品,加拿大主要通过计算国际价格比值,进而进行双边比较和多边比较来监测其药品价格。目前加拿大已实现对药品价格的有效监测,即引入期的新药价格符合《过高价格指南》;已上市的专利药价格低于国际价格水平;非专利药价格水平与国际水平的价格差异已逐步减小。结论:建议我国借鉴加拿大药价监测经验,增加对药品价格监测的立法,分类确定监测品种,并探索建立以国际参考价格为警兆指标的药价监测预警机制。
[Abstract]:Objective: to analyze and summarize the drug price monitoring model based on international reference price in Canada, in order to provide reference for the improvement of drug price monitoring system in China. Methods: through policy analysis and literature research, Results: for new drugs in the period of introduction, Canada uses the international median price comparison test, the highest international price comparison test, and the highest international price comparison test. There are four methods for monitoring the price of drugs in domestic treatment category comparison test and international treatment category comparison test. For listed drugs, Canada mainly calculates the international price ratio. In turn, bilateral and multilateral comparisons are carried out to monitor their drug prices. Canada has now achieved effective monitoring of drug prices. That is, the price of new drugs in the period of introduction conforms to the "Guide to excessive Price", and the price of patented drugs on the market is lower than the international price level; The price difference between generic drug price level and international level has gradually decreased. Conclusion: it is suggested that our country should draw lessons from Canadian experience in drug price monitoring, increase legislation on drug price monitoring, and classify the monitoring varieties. And explore the establishment of international reference price as a warning indicator of drug price monitoring and early warning mechanism.
【作者单位】：沈阳药科大学工商管理学院;
【分类号】：R95

【参考文献】